CSF NfL is a biomarker in several diseases characterized by axonal loss, including stroke, small vessel disease, head injury, amyotrophic lateral sclerosis, Alzheimer's disease, Huntington's disease, acute spinal cord injury, NMOSD, and MS (7). Here, NEFL is linked to myeloid sarcoma.